Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Cure My Disease

Don't miss your cure!

 Log in / Sign up

New robotic arm exoskeleton aims to restore daily function after stroke or nerve injury

NCT ID NCT07000279

Symptom relief Sponsor: Istituto Nazionale Assicurazione contro gli Infortuni sul Lavoro Source: ClinicalTrials.gov ↗

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now This study
This trial is taking on new participants right now.
Not yet recruiting
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing
Running, but no longer taking on new participants.
Completed
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This pilot study is testing a portable hybrid exoskeleton that combines a robotic arm support with electrical stimulation to help people with upper limb deficits from stroke or brachial plexus injuries. Ten participants will perform tasks like moving blocks and daily activities with and without the device to see if it improves movement and usability. The goal is to assess safety, performance, and user satisfaction.

What this could mean

Our plain-language read of the trial. This is informational only, not medical advice or a prediction.

Active substance
hybrid assistive exoskeleton (robotic exoskeleton plus functional electrical stimulation)
What this could lead to
If it works, this device could help people with arm weakness regain independence in daily activities like eating and drinking.
What could go wrong
This is a very small pilot study with only 10 participants, so results may not apply to everyone. The device is still experimental and may have technical issues or not provide enough benefit.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Phase

Not a phased trial

Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.

Participants

About 10 people

The number the study aims to enrol. It can still change while the study runs.

Started

Sep 2025

Expected to finish

Dec 2025

An estimate. End dates often move.

Lead sponsor

Other sponsor

The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Ages

18 to 65 years

Sex

Anyone

Healthy volunteers

Accepted

You do not need to have the condition being studied to take part.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: * age between 18 and 65 years * post-stroke or brachial plexus injuries patients * upper limb motor deficit patients with Medical Research Council (MRC) Scale for Muscle Strength equal to or more than 2 * number of months after lesion higher than 6 * cognitive ability to follow instruction * no Functional Electrical Stimulation (FES) treatment within 6 months prior to the enrollment * absence of communication deficit Exclusion Criteria: * other nuerological or orthopaedic impairments * pain in injuried upper limb (Numeric Rating Scale (NRS) higher than 4) * cognitive impairments (Mini-Mental State Examination (MMSE) lower than 24) * implantable devices that can interfere with FES * muscle/neurological diseases that can get worse with FES * fever or infection * pregnancy or breastfeeding * absence of patient informed consent in written form * unstable medical condition

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Brachial plexus injuries are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Conditions

The condition(s) this trial relates to.

brachial plexus neuropathy from injury stroke disorder

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Upper limb deficits

How to take part

Only the study team decides who joins. These are the ways to reach them.

  1. The places running it

    1 site. The list below names each one and where it is.

  2. The official record

    ClinicalTrials.gov lists the study team's own contact details, including names and phone numbers. We don't republish those.

    Open the record ↗

  3. A doctor treating you

    A doctor who knows your case can contact a study site on your behalf, and can tell you whether this study is worth pursuing at all.

Contacts and locations

Locations

  • Centro Protesi Inail

    RECRUITING

    Budrio, Bologna, 40054, Italy

More trials for these conditions

Other studies related to the condition(s) this trial covers.